Skip to main content

Table 2 Score distribution of the SF-36 (2 summary measures) at hospital and after 12 months (per-protocol-analysis)

From: Health-Related Quality of Life after Ischemic Stroke: The Impact of Pharmaceutical Interventions on Drug Therapy (Pharmaceutical Care Concept)

    IG (n = 64) CG (n = 119) After 12 months
Between group comparison
SF-36 Scales   time mean
(± SD)
mean
(± SD)
p-Value †
PCS   Hospital 41.8 (± 9.8) 41.2 (± 10.8)  
   After 12 months 41.5 (± 11.0) 38.1 (± 11.6) 0.090
  p-Value ‡ Differences between baseline and after 12 months 0.313 0.023*  
MCS   Hospital 49.5 (± 10.6) 49.6 (± 11.7)  
   After 12 months 48.1 (± 11.3) 45.0 (± 10.9) 0.077
  p-Value ‡ Differences between baseline and after 12 months 0.831 0.001***  
  1. SD = Standard deviation.
  2. = The Mann-Whitney U test was used to compare the distribution of ranks between the groups.
  3. = The Wilcoxon Rank sum test was chosen to identify differences in each group at baseline and after 12 months.